disclosures
play

Disclosures The faculty reported the following relevant financial - PowerPoint PPT Presentation

Disclosures The faculty reported the following relevant financial relationships during the content development process for this activity: Ramzan Zakir, MD, FSCAI Sahil A. Parikh, MD, FSCAI Abbott (St. Jude): Consulting; Boston Scientific:


  1. Disclosures The faculty reported the following relevant financial relationships during the content development process for this activity: Ramzan Zakir, MD, FSCAI Sahil A. Parikh, MD, FSCAI Abbott (St. Jude): Consulting; Boston Scientific: Advisory Board, Abbott (St. Jude): Advisory Board; Asahi: Consulting; Boston Consulting, Speakers Bureau; Cardiovascular Systems, Inc.: Scientific: Advisory Board; Cardiovascular Systems, Inc.: Advisory Consulting Board; Heartflow: Consulting, Speakers Bureau; Medtronic: Advisory Board; Merril Lifesciences: Consulting; Shockwave Sanjum Sethi, MD, MPH Medical: Principal Investigator; Silk Road Medical: DSMB; Nothing to disclose. Terumo: Consulting; TriReme Medical: Principal Investigator Mohammad A. Ansari, MD, FSCAI Nothing to disclose. CME Oversight Committee reviewers Waqar H. Ahmed, MD, MS, FSCAI, and Babu Ezhumalai, MD, DM, FNB, FSCAI, reported Jihad A. Mustapha, MD, FSCAI no financial relationships. Bard Peripheral Vascular: Consulting; Boston Scientific: Consulting; CardioFlow: Ownership Interests (Stocks, Stock Options); Medtronic: Consulting; Philips: Consulting; Terumo: Consulting SCAI staff associated with the development of content for this activity, Robert Bartel, MSc, FACEHP , and Laura Daigle Porter, CMP , reported no relevant financial relationships.

  2. Accreditation Statement The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SCAI designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  3. Learning Objectives • Upon completion of this activity, participants will be able to: • Define the changing landscape for critical limb ischemia (CLI) diagnosis and treatment. • Review crossing devices and techniques for SFA and tibial chronic total occlusions. • Discuss the role of atherectomy below the knee. • Individualize patient treatment from available therapies for CLI

  4. Evaluation and Certificates • Evaluations are available through the SCAI 2019 app. • Please claim credit within 30 days of the meeting.

  5. Agenda Moderator: Sahil A. Parikh, MD, FSCAI Time to Redefine Critical Limb Ischemia Distal Foot Reconstruction: Why and How Case 1: Perfusion Challenges Case 4: Pedal Disease Sahil A. Parikh, MD, FSCAI Ramzan Zakir, MD, FSCAI Access and Crossing Techniques How to Address Complex Popliteal Disease in a Case 2: Crossing CTOs Patient with Significant Below the Knee Disease: My Approach Mohammad M. Ansari, MD Case 5: Complex SFA/POP in a CLI Patient Sanjum Sethi, MD, MPH Debulking Below the Knee: Devices and Techniques Case 3: Atherectomy Jihad A. Mustapha, MD, FSCAI

Recommend


More recommend